[Oncology : what's new in 2025].

Among the many oncology breakthroughs, this article focuses on three significant advances that are particularly relevant to Switzerland: endometrial cancer, which is now better defined by molecular biomarkers, oncogeriatrics, which has become a standard in light of an aging population, and pancreatic cancer, for which solutions have long been lacking, but where early detection tools and new targeted therapies are finally emerging. These are three modern, concrete, and hopeful topics.